BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25033840)

  • 1. Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.
    Schneider G; Sellers ZP; Abdel-Latif A; Morris AJ; Ratajczak MZ
    Mol Cancer Res; 2014 Nov; 12(11):1560-73. PubMed ID: 25033840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.
    Schneider G; Bryndza E; Abdel-Latif A; Ratajczak J; Maj M; Tarnowski M; Klyachkin YM; Houghton P; Morris AJ; Vater A; Klussmann S; Kucia M; Ratajczak MZ
    Mol Cancer Res; 2013 Jul; 11(7):793-807. PubMed ID: 23615526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
    Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
    J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis.
    Schneider G; Sellers ZP; Bujko K; Kakar SS; Kucia M; Ratajczak MZ
    Oncotarget; 2017 Aug; 8(35):58247-58263. PubMed ID: 28938552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
    Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
    Sevastou I; Kaffe E; Mouratis MA; Aidinis V
    Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.
    Abdelbaset-Ismail A; Cymer M; Borkowska-Rzeszotek S; Brzeźniakiewicz-Janus K; Rameshwar P; Kakar SS; Ratajczak J; Ratajczak MZ
    Stem Cell Rev Rep; 2019 Feb; 15(1):139-154. PubMed ID: 30302660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
    Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
    Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.
    Itoh R; Miura S; Takimoto A; Kondo S; Sano H; Hiraki Y
    J Bone Miner Metab; 2010 Nov; 28(6):659-71. PubMed ID: 20458606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
    Komachi M; Sato K; Tobo M; Mogi C; Yamada T; Ohta H; Tomura H; Kimura T; Im DS; Yanagida K; Ishii S; Takeyoshi I; Okajima F
    Cancer Sci; 2012 Jun; 103(6):1099-104. PubMed ID: 22348348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
    Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
    Park JJ; Rubio MV; Zhang Z; Um T; Xie Y; Knoepp SM; Snider AJ; Gibbs TC; Meier KE
    Prostate; 2012 Nov; 72(15):1595-610. PubMed ID: 22473839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes.
    Honjo M; Igarashi N; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Weinreb RN; Aihara M
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):693-701. PubMed ID: 29392315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
    Uranbileg B; Ito N; Kurano M; Saigusa D; Saito R; Uruno A; Kano K; Ikeda H; Yamada Y; Sumitani M; Sekiguchi M; Aoki J; Yatomi Y
    Sci Rep; 2019 Nov; 9(1):16578. PubMed ID: 31719574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.
    Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Li HY; Oh YS; Choi JW; Jung JY; Jun HS
    Kidney Int; 2017 Jun; 91(6):1362-1373. PubMed ID: 28111010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells.
    Nochi H; Tomura H; Tobo M; Tanaka N; Sato K; Shinozaki T; Kobayashi T; Takagishi K; Ohta H; Okajima F; Tamoto K
    J Immunol; 2008 Oct; 181(7):5111-9. PubMed ID: 18802115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.